New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
GeneDx Holdings Corp.
WGS
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

1B

Medical - Healthcare Information Services

Next Earning date - 04 Nov 2024

1B

Medical - Healthcare Information Services

Next Earning date - 04 Nov 2024

47.12USD
Shape1.59 ( 3.49%)
favorite-chart

Relative Strenght

99
favorite-chart

Volume Buzz

51%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

0%

Quote Panel

Shape
Updated October 4, 2024
1W 11.10 % 1M 44.54 % 3M 63.09 % 1Y 1324.47 %

Key Metrics

Shape
  • Market Cap

    1.27B


  • Shares Outstanding

    26.94M


  • Share in Float

    19.13M


  • Dividende

    0


  • Earning Date

    04 Nov 2024


  • Price Target

    47.12


  • Average Volume

    433582


  • Beta

    2.383


  • Range

    1.16-47.21


  • Industry

    Medical - Healthcare Information Services


  • Website

    http://www.genedx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

5.03x

P/S Ratio

6.25x

P/B Ratio

0.3

Debt/Equity

-48.2%

Net Margin

$-4.4

EPS

How WGS compares to sector?

P/E Ratio

Relative Strength

Shape

WGS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$301M

Shape327%

2025-Revenue

$0.59

Shape46%

2025-EPS

$226M

Shape-4586%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Wells Fargo

initialise

Previous: Not converted

2024-08-27

Now: Equal-Weight

Craig-Hallum

initialise

Previous: Not converted

2024-07-10

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.20
vs -0.43

Q4.22

arrow
arrow

N/A

-0.25
vs -0.17

Q1.23

arrow
arrow

N/A

-2.82
vs -0.31

Q2.23

arrow
arrow

N/A

-1.65
vs -0.25

Q3.23

arrow
arrow

N/A

-0.82
vs -0.20

Q4.23

arrow
arrow

N/A

-0.59
vs -0.25

Q1.24

arrow
arrow

N/A

-0.33
vs -2.82

Q2.24

arrow
arrow

N/A

-0.11
vs -1.65

Q3.24

arrow
arrow

N/A

-0.26
vs -0.82

Q4.24

arrow
arrow

N/A

-0.21
vs -0.59

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+93%

83.2M  vs 43.2M

Q4.22

arrow
arrow

+6%

61.4M  vs 57.8M

Q1.23

arrow
arrow

-20%

43.1M  vs 53.9M

Q2.23

arrow
arrow

+35%

48.7M  vs 36.2M

Q3.23

arrow
arrow

-36%

53.3M  vs 83.2M

Q4.23

arrow
arrow

-6%

57.4M  vs 61.4M

Q1.24

arrow
arrow

+45%

62.4M  vs 43.1M

Q2.24

arrow
arrow

+45%

70.5M  vs 48.7M

Q3.24

arrow
arrow

+22%

65M  vs 53.3M

Q4.24

arrow
arrow

+17%

67.1M  vs 57.4M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-14%

-0.14
vs -0.13

Q4.22

arrow
arrow

-122%

-1.22
vs -0.14

Q1.23

arrow
arrow

-19%

-0.19
vs -1.22

Q2.23

arrow
arrow

-16%

-0.16
vs -0.19

Q3.23

arrow
arrow

-17%

-0.17
vs -0.16

Q4.23

arrow
arrow

-11%

-0.11
vs -0.17

Q1.24

arrow
arrow

-10%

-0.10
vs -0.11

Q2.24

arrow
arrow

-15%

-0.15
vs -0.10

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News